Skip to main content
Premium Trial:

Request an Annual Quote

Chicago Sewage Search

Chicago plans to begin testing the city's sewage to gauge the level of SARS-CoV-2 infections there, the Chicago Tribune reports. As the virus appears to crop up in sewage samples about a week before people begin seeking treatment at hospitals, the hope is that testing will enable hospitals and healthcare workers to prepare and brace for an upswing in COVID-19 cases.

Other cities and even a university have adopted this testing approach. In April, Mariana Matus, the co-founder of Biobot Analytics, and her colleagues applied their company's testing approach to wastewater samples from Massachusetts to find they could detect SARS-CoV-2 in samples from after the pandemic began, but not before. The Verge reported in June that cities like New Haven, Connecticut, and Carmel, Indiana, adopted testing either by Biobot or similar testing by Yale scientists. Additionally, the University of Arizona tested wastewater from dorms to spot COVID-19 outbreaks.

The Tribune notes that, in Chicago, part of the challenge of implementing testing will be determining where in the 4,500 miles of city sewers to sample and navigating rivalries between the Chicago Department of Water Management and the Metropolitan Water Reclamation District. It adds that, currently, officials from the water district are sending samples from three treatment plants for analysis by Stanford University and University of Michigan researchers, who are sharing the results with researchers from Illinois universities who, in turn, are modeling whether neighborhood-level sampling could identify local hotspots. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.